| Literature DB >> 33330655 |
Jinyu Wang1,2,3, Bowen Lin2,3, Yanping Zhang4, Le Ni2,3, Lingjie Hu2,3, Jian Yang2,3, Liang Xu2,3, Dan Shi2,3, Yi-Han Chen1,2,3,5.
Abstract
Myocardial infarction (MI) is a fatal heart disease with high morbidity and mortality. Various studies have demonstrated that a series of relatively specific biological events occur within 24 h of MI. However, the roles of histone modifications in this pathological process are still poorly understood. To investigate the regulation of histone modifications on gene expression in early MI, we performed RNA sequencing (RNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) on myocardial tissues 24 h after the onset of MI. The genome-wide profiles of five histone marks (H3K27ac, H3K9ac, H3K4me3, H3K9me3, and H3K27me3) were explored through ChIP-seq. RNA-seq identified 1,032 differentially expressed genes (DEGs) between the MI and sham groups. ChIP-seq analysis found that 195 upregulated DEGs were modified by change of at least one of the three active histone marks (H3K27ac, H3K9ac, and H3K4me3), and the biological processes and pathways analysis showed that these DEGs were significantly enriched in cardiomyocyte differentiation and development, inflammation, angiogenesis, and metabolism. In the transcriptional regulatory network, Ets1, Etv1, and Etv2 were predicted to be involved in gene expression regulation. In addition, by integrating super-enhancers (SEs) with RNA-seq data, 76 DEGs were associated with H3K27ac-enriched SEs in the MI group, and the functions of these SE-associated DEGs were mainly related to angiogenesis. Our results suggest that histone modifications may play important roles in the regulation of gene expression in the early stage of MI, and the early angiogenesis response may be initiated by SEs.Entities:
Keywords: epigenomics; histone modification; super-enhancer; transcription factors; transcriptome
Year: 2020 PMID: 33330655 PMCID: PMC7734124 DOI: 10.3389/fcvm.2020.594325
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Transcriptome analysis and histone modification profiling in the early stage of myocardial infraction (MI), (A) Schematic illustration of the present study. (B) Volcano plots showing the differentially expressed genes (DEGs) between sham and MI groups. Blue dots represent downregulated genes, and red dots represent upregulated genes. (C) Gene ontology (GO) analysis of the differentially expressed genes (DEGs) in RNA-seq. Orange bras represent the enrichment of upregulated genes; blue bars represent the enrichment of downregulated genes. (D) Hierarchical clustering of H3K9ac, H3K9me3, H3K27ac, H3K27me3, and H3K4me3 occupancy at genome wide in sham and MI group. Spearman correlation coefficient was used to calculate sample correlations. (E) The genomic distribution of different histone modification regions in sham and MI groups.
Information of the peaks called in different samples.
| MI24-input_rep1 | 59,329,700 | 57,982,915 | 97.73 | |||
| MI24-input_rep2 | 48,793,596 | 47,954,346 | 98.28 | |||
| MI24-input_rep3 | 73,326,196 | 72,145,644 | 98.39 | |||
| MI24-H3K27ac_rep1 | 55,638,462 | 52,016,398 | 93.49 | 46,521 | 153,946,563 | 3,309.18 |
| MI24-H3K27ac_rep2 | 48,204,386 | 47,539,165 | 98.62 | 43,004 | 146,496,195 | 3,406.57 |
| MI24-H3K27ac_rep3 | 58,656,804 | 57,536,459 | 98.09 | 50,192 | 156,520,708 | 3,118.44 |
| MI24-H3K27me3_rep1 | 63,728,706 | 62,568,843 | 98.18 | 31,551 | 112,026,446 | 3,550.65 |
| MI24-H3K27me3_rep2 | 51,994,578 | 51,282,252 | 98.63 | 26,864 | 106,249,613 | 3,955.09 |
| MI24-H3K27me3_rep3 | 57,951,114 | 56,896,403 | 98.18 | 38,652 | 143,281,067 | 3,706.95 |
| MI24-H3K4me3_rep1 | 61,403,310 | 60,193,664 | 98.03 | 17,023 | 41,311,218 | 2,426.79 |
| MI24-H3K4me3_rep2 | 46,460,220 | 45,763,316 | 98.5 | 16,072 | 38,907,043 | 2,420.8 |
| MI24-H3K4me3_rep3 | 65,778,746 | 64,318,457 | 97.78 | 20,150 | 50,138,955 | 2,488.29 |
| MI24-H3K9ac_rep1 | 51,708,148 | 50,761,888 | 98.17 | 24,819 | 64,439,753 | 2,596.39 |
| MI24-H3K9ac_rep2 | 37,375,860 | 35,981,740 | 96.27 | 32,902 | 78,887,608 | 2,397.65 |
| MI24-H3K9ac_rep3 | 58,058,296 | 57,077,110 | 98.31 | 42,726 | 122,678,660 | 2,871.29 |
| MI24-H3K9me3_rep1 | 58,645,664 | 57,437,563 | 97.94 | 19,934 | 36,535,935 | 1,832.85 |
| MI24-H3K9me3_rep2 | 46,441,950 | 45,568,841 | 98.12 | 19,821 | 34,529,866 | 1,742.08 |
| MI24-H3K9me3_rep3 | 58,184,316 | 56,671,523 | 97.4 | 23,662 | 41,583,430 | 1,757.39 |
| Sham-input_rep1 | 65,704,850 | 64,574,726 | 98.28 | |||
| Sham-input_rep2 | 54,637,390 | 53,675,771 | 98.24 | |||
| Sham-H3K27ac_rep1 | 58,613,224 | 57,739,886 | 98.51 | 49,891 | 160,041,629 | 3,207.83 |
| Sham-H3K27ac_rep2 | 51,299,442 | 50,545,340 | 98.53 | 44,392 | 125,831,890 | 2,834.56 |
| Sham-H3K27me3_rep1 | 59,835,338 | 58,429,207 | 97.65 | 35,099 | 136,040,218 | 3,875.9 |
| Sham-H3K27me3_rep2 | 51,733,232 | 50,734,780 | 98.07 | 36,054 | 113,291,599 | 3,142.28 |
| Sham-H3K4me3_rep1 | 48,939,496 | 48,229,873 | 98.55 | 16,772 | 37,584,277 | 2,240.89 |
| Sham-H3K4me3_rep2 | 58,911,408 | 57,462,187 | 97.54 | 17,218 | 42,505,603 | 2,468.67 |
| Sham-H3K9ac_rep1 | 53,257,144 | 52,421,006 | 98.43 | 29,625 | 84,340,323 | 2,846.93 |
| Sham-H3K9ac_rep2 | 56,017,696 | 55,059,793 | 98.29 | 26,963 | 74,877,575 | 2,777.05 |
| Sham-H3K9me3_rep1 | 52,185,442 | 51,167,825 | 98.05 | 21,950 | 35,551,960 | 1,619.68 |
| Sham-H3K9me3_rep2 | 52,790,998 | 51,756,294 | 98.04 | 22,301 | 37,809,809 | 1,695.43 |
Figure 2Epigenetic profile change in the early stage of MI. (A) The average signals of each histone mark relative to ±3 kb of the transcription start site (TSS) between the sham and MI group. (B) The number of MI unique peaks in promoters of H3K9ac, H3K9me3, H3K27ac, H3K27me3, and H3K4me3 marks. (C) GO analysis of the MI unique peaks in promoters of H3K9ac, H3K27ac, H3K27me3, and, H3K4me3 marks.
Figure 3The upregulated genes associated with gain of active histone marks. (A) Venn diagram showing upregulated DEGs associated with the open regions in the promoters (gain of H3K9ac, H3K27ac, and H3K4me3 marks in the ±2 kb from TSS). (B) GO analysis of the upregulated DEGs enriched in promoters (±2 kb from TSS) of H3K9ac, H3K27ac, and H3K4me3 marks. (C) Kyoto Encyclopedia of Genes and Genomes (KEGGs) pathway enrichment analysis of the upregulated DEGs enriched in promoters (±2 kb from TSS) of H3K9ac, H3K27ac, and H3K4me3 marks. (D) Heatmap showing the relative expression fragments per kilobase million (FPKM) of genes related to inflammatory response processes. (E,F) The increased active histone marks at promoters and enhancers of Cxcl2 and Cxcl3 in MI compared with the sham group. (G) ChIP-qPCR validation of the distribution of H3K27ac changes in Cxcl2 and Cxcl3. (H) qPCR validation of the expression of Cxcl2 and Cxcl3. (I) The transcription factors and binding motifs identified at promoter regions of upregulated DEGs enriched for H3K9ac, H3K27ac, and H3K4me3. n = 3; *P < 0.05, ***P < 0.001.
Figure 4Identification of MI specific super-enhancers (SEs). (A) Ranked plots of typical enhancers (TEs) and super enhancers (SEs) in the sham and MI group by increasing H3K27ac signal (normalized by the ratio to the highest H3K27ac reads of the enhancer). The axes values represent the ranks of enhancers by H3K27ac signal. Angiogenesis-related genes are marked out in the figures. (B) The expression (Log2) of TE-associated genes vs. SE-associated genes in the MI group. P-value was determined by the Wilcoxon test. (C) Overlapping genes of DEGs and SE-associated genes in the MI group. The MI unique SE-associated genes and common SE-associated genes are listed. (D) GO analysis of the 76 overlapping genes between DEGs and SE-associated genes in the MI group. (E) The specific genes in the angiogenesis-related GO terms. (F) The H3K27ac occupancy of two representative angiogenesis-related genes Itgb2 and Ccl2 is shown. The red and gray peaks, respectively, mean MI and sham group. (G,H) Itgb2- and Ccl2-associated SEs on human umbilical vein endothelial cells (HUVECs) and human skeletal muscle myoblasts (HSMM) from ENCODE project.